File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1007/s10388-004-0027-z
- Scopus: eid_2-s2.0-41549085535
- Find via
Supplementary
-
Citations:
- Scopus: 0
- Appears in Collections:
Conference Paper: Current status of esophageal cancer treatment in Asia
Title | Current status of esophageal cancer treatment in Asia |
---|---|
Authors | |
Keywords | Esophageal cancer Esophagectomy Resection Multimodal treatment |
Issue Date | 2004 |
Publisher | Springer Japan. The Journal's web site is located at http://link.springer.com/journal/10388 |
Citation | The 58th Annual Meeting of the Japan Esophageal Society (JES), Tokyo, Japan, 24-25 June 2004. In Esophagus, 2004, v. 1 n. 4, p. 169-176 How to Cite? |
Abstract | Esophageal cancer is becoming a different disease in Asian and Western countries. The rapidly rising incidence of adenocarcinoma of the lower esophagus and cardia has replaced squamous cell cancers as the predominant cell type in the west. The different cell type and tumor location to some extent influence how the disease is treated; other factors are cultural and the way health care is financed. The goals of treatment, however, are the same; to provide long-term cure with minimal morbidity and mortality and to preserve patients’ quality of life. Surgical resection has remained the mainstay treatment in Asia. Improvement in surgical outcome has taken place in many centers throughout Asia in the past two decades. Emphasis has been centered on epidemiology of the disease, reducing morbidity and mortality of esophagectomy, and identifying effective surgical or nonsurgical methods of treatments. Randomized controlled trials are also increasingly employed to test many unresolved problems. The Asian contributions are elaborated with specific examples from Japan, Hong Kong, and China. |
Persistent Identifier | http://hdl.handle.net/10722/84247 |
ISSN | 2023 Impact Factor: 2.2 2023 SCImago Journal Rankings: 0.859 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Law, SYK | en_HK |
dc.contributor.author | Wong, J | en_HK |
dc.date.accessioned | 2010-09-06T08:50:42Z | - |
dc.date.available | 2010-09-06T08:50:42Z | - |
dc.date.issued | 2004 | en_HK |
dc.identifier.citation | The 58th Annual Meeting of the Japan Esophageal Society (JES), Tokyo, Japan, 24-25 June 2004. In Esophagus, 2004, v. 1 n. 4, p. 169-176 | en_HK |
dc.identifier.issn | 1612-9059 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/84247 | - |
dc.description.abstract | Esophageal cancer is becoming a different disease in Asian and Western countries. The rapidly rising incidence of adenocarcinoma of the lower esophagus and cardia has replaced squamous cell cancers as the predominant cell type in the west. The different cell type and tumor location to some extent influence how the disease is treated; other factors are cultural and the way health care is financed. The goals of treatment, however, are the same; to provide long-term cure with minimal morbidity and mortality and to preserve patients’ quality of life. Surgical resection has remained the mainstay treatment in Asia. Improvement in surgical outcome has taken place in many centers throughout Asia in the past two decades. Emphasis has been centered on epidemiology of the disease, reducing morbidity and mortality of esophagectomy, and identifying effective surgical or nonsurgical methods of treatments. Randomized controlled trials are also increasingly employed to test many unresolved problems. The Asian contributions are elaborated with specific examples from Japan, Hong Kong, and China. | - |
dc.language | eng | en_HK |
dc.publisher | Springer Japan. The Journal's web site is located at http://link.springer.com/journal/10388 | en_HK |
dc.relation.ispartof | Esophagus | en_HK |
dc.rights | The original publication is available at www.springerlink.com | - |
dc.subject | Esophageal cancer | - |
dc.subject | Esophagectomy | - |
dc.subject | Resection | - |
dc.subject | Multimodal treatment | - |
dc.title | Current status of esophageal cancer treatment in Asia | en_HK |
dc.type | Conference_Paper | en_HK |
dc.identifier.email | Law, SYK: slaw@hku.hk | en_HK |
dc.identifier.email | Wong, J: jwong@hkucc.hku.hk | en_HK |
dc.identifier.authority | Wong, J=rp00322 | en_HK |
dc.identifier.doi | 10.1007/s10388-004-0027-z | - |
dc.identifier.scopus | eid_2-s2.0-41549085535 | - |
dc.identifier.hkuros | 99973 | en_HK |
dc.identifier.hkuros | 92022 | - |
dc.identifier.volume | 1 | - |
dc.identifier.issue | 4 | - |
dc.identifier.spage | 169 | - |
dc.identifier.epage | 176 | - |
dc.publisher.place | Japan | - |
dc.description.other | The 58th Annual Meeting of the Japan Esophageal Society, Tokyo, Japan, 24-25 June 2004. In Esophagus, 2004, v. 1 n. 4, p. 169-176 | - |
dc.customcontrol.immutable | sml 170523 amended | - |
dc.identifier.issnl | 1612-9059 | - |